Iovance Biotherapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Iovance Biotherapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Iovance Biotherapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Iovance Biotherapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Iovance Biotherapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 10 Jul 2023 | Iovance Biotherapeutics Raises USD172.5 Million in Public Offering of Shares | Equity Offering | - |
Iovance Biotherapeutics Inc |
| 18 May 2023 | Iovance Biotherapeutics Acquires Clinigen SP | Acquisition |
Iovance Biotherapeutics Inc
|
Clinigen SP Ltd
|
| 23 Jan 2023 | Iovance Biotherapeutics to Acquire Proleukin from Clinigen for USD206.64 Million | Asset Transaction |
Iovance Biotherapeutics Inc
|
Clinigen Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer